Clindamycin Palmitate Hydrochloride
ANDA 203513, held by Amneal Pharms. Clindamycin Palmitate Hydrochloride.
- First approved: Mar 13, 2014
- Supplements approved: 0
- Complete response letters: 0
Approvals and New Uses
The original application and every efficacy supplement, newest first| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 13, 2014 | Original application | Approved | None posted |
Products
1 strengths and forms| Product | Active ingredient | Marketing |
|---|---|---|
| Clindamycin Palmitate HydrochlorideEQ 75MG BASE/5ML · for solution;oral | Clindamycin Palmitate Hydrochloride | Discontinued |
Identifiers
- Application
- ANDA 203513
- Drugs@FDA
- Overview at FDA
- Company
- Amneal Pharmaceuticals
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed weekly; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters